277 related articles for article (PubMed ID: 19903674)
1. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
[TBL] [Abstract][Full Text] [Related]
3. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
De Botton S; Chevret S; Sanz M; Dombret H; Thomas X; Guerci A; Fey M; Rayon C; Huguet F; Sotto JJ; Gardin C; Cony Makhoul P; Travade P; Solary E; Fegueux N; Bordessoule D; San Miguel J; Link H; Desablens B; Stamatoullas A; Deconinck E; Geiser K; Hess U; Maloisel F; Castaigne S; Preudhomme C; Chomienne C; Degos L; Fenaux P;
Br J Haematol; 2000 Dec; 111(3):801-6. PubMed ID: 11122141
[TBL] [Abstract][Full Text] [Related]
4. Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia: 10-year results of the Japan Adult Leukemia Study Group APL97 study.
Ono T; Takeshita A; Iwanaga M; Asou N; Naoe T; Ohno R;
Haematologica; 2011 Jan; 96(1):174-6. PubMed ID: 20884714
[No Abstract] [Full Text] [Related]
5. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.
Schnittger S; Bacher U; Haferlach C; Kern W; Alpermann T; Haferlach T
Haematologica; 2011 Dec; 96(12):1799-807. PubMed ID: 21859732
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
Barragán E; Montesinos P; Camos M; González M; Calasanz MJ; Román-Gómez J; Gómez-Casares MT; Ayala R; López J; Fuster Ó; Colomer D; Chillón C; Larrayoz MJ; Sánchez-Godoy P; González-Campos J; Manso F; Amador ML; Vellenga E; Lowenberg B; Sanz MA; ;
Haematologica; 2011 Oct; 96(10):1470-7. PubMed ID: 21685470
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment.
Chou WC; Tang JL; Yao M; Liang YJ; Lee FY; Lin MT; Wang CH; Shen MC; Chen YC; Tien HF
Leukemia; 1997 Jul; 11(7):921-8. PubMed ID: 9204969
[TBL] [Abstract][Full Text] [Related]
8. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel JD; Brunet S; Tomás JF; Tormo M; Sayas MJ; Sánchez Godoy P; Colomer D; Bolufer P; Sanz MA;
Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
[TBL] [Abstract][Full Text] [Related]
10. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
[No Abstract] [Full Text] [Related]
11. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
Dalal BI; Bruyere H; Barnett MJ
Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
[No Abstract] [Full Text] [Related]
12. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
13. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
Mandelli F; Diverio D; Avvisati G; Luciano A; Barbui T; Bernasconi C; Broccia G; Cerri R; Falda M; Fioritoni G; Leoni F; Liso V; Petti MC; Rodeghiero F; Saglio G; Vegna ML; Visani G; Jehn U; Willemze R; Muus P; Pelicci PG; Biondi A; Lo Coco F
Blood; 1997 Aug; 90(3):1014-21. PubMed ID: 9242531
[TBL] [Abstract][Full Text] [Related]
14. Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence.
Pantic M; Novak A; Marisavljevic D; Djordjevic V; Elezovic I; Vidovic A; Colovic M
Med Oncol; 2000 Nov; 17(4):307-13. PubMed ID: 11114710
[TBL] [Abstract][Full Text] [Related]
15. Clinico-biological features of 30 patients with acute promyelocytic leukemia and response to combination induction chemotherapy with all-trans retinoic acid and anthracycline.
Lim LC; Vellupillai M; Ghafar AA
Med Oncol; 2000 Nov; 17(4):301-6. PubMed ID: 11114709
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case.
Specchia G; Storlazzi CT; Cuneo A; Surace C; Mestice A; Pannunzio A; Rocchi M; Liso V
Ann Hematol; 2001 Apr; 80(4):246-50. PubMed ID: 11401094
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Montesinos P; Díaz-Mediavilla J; Debén G; Prates V; Tormo M; Rubio V; Pérez I; Fernández I; Viguria M; Rayón C; González J; de la Serna J; Esteve J; Bergua JM; Rivas C; González M; González JD; Negri S; Brunet S; Lowenberg B; Sanz MA
Haematologica; 2009 Sep; 94(9):1242-9. PubMed ID: 19608685
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia with del(6)(p23).
Nakase K; Wakita Y; Minamikawa K; Yamaguchi T; Shiku H
Leuk Res; 2000 Jan; 24(1):79-81. PubMed ID: 10634650
[TBL] [Abstract][Full Text] [Related]
19. Trisomy 21 and other chromosomal abnormalities in acute promyelocytic leukemia.
Wan TS; Ma SK; Au WY; Liu HS; Chan JC; Chan LC
Cancer Genet Cytogenet; 2003 Jan; 140(2):170-3. PubMed ID: 12645658
[TBL] [Abstract][Full Text] [Related]
20. PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide.
Baba SM; Azad NA; Shah ZA; Afroze D; Pandith AA; Jan A; Aziz SA; Dar FA
Asian Pac J Cancer Prev; 2016; 17(4):1999-2006. PubMed ID: 27221887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]